DIABETES MELLITUS IN WOLFRAM SYNDROME 1: CHARACTERISTICS AND PERSPECTIVES IN TREATMENT
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5533Keywords:
Cell Regenerative Therapy, GLP-1 Receptor Agonists, Wolfram Syndrome 1, Diabetes Mellitus, Islet TransplantationAbstract
Wolfram syndrome 1 is a rare autosomal recessive disorder caused by mutations in the WFS1 gene related to endoplasmic reticulum (ER) function. The course of the disease most often begins with diagnosis of insulin-dependent non-autoimmune diabetes mellitus with an early onset. Its clinical character is presented with an acronym DIDMOAD: diabetes insipidus (DI), diabetes mellitus (DM), optic atrophy (OA) and deafness (D).
This article focuses on the clinical features of diabetes mellitus in Wolfram syndrome. We also describe current approach to its therapy and discuss possible treatment options placing the main emphasis on the GLP1 receptor agonists and cell regenerative therapy.
Methods and materials: A qualitative synthesis of the data focusing on GLP-1 agonists, cell regenerative therapy and diabetes mellitus in Wolfram syndrome was performed. This literature review of GLP-1 receptor agonists and cell regenerative therapy effect on metabolic control, and current perspectives of treatment in patients with Wolfram syndrome, a monogenic type of diabetes, included recent publications, primarily from the past 10 years, and was conducted from November 2025 to April 2026 using the PubMed database.
A systematic search was performed using specific keywords and medical subject headings (MeSH terms) related to GLP-1 agonists and Wolfram syndrome. The primary search terms included: “diabetes mellitus”, “GLP-1 agonists”, “Wolfram syndrome”, “WFS1”, “monogenic diabetes”, “islet transplantation”, and “cell regenerative therapy”. The criteria for inclusion of articles were as follows: published before April 2026, written in English, peer-reviewed original research articles. Exclusion criteria included publications not available in full text, articles in languages other than English. Editorials, commentaries, and conference abstracts without full data were also excluded. Titles and abstracts of the retrieved articles were screened to determine eligibility based on the inclusion and exclusion criteria.
References
Bueno, G. E., Ruiz-Castañeda, D., Martínez, J. R., Muñoz, M. R., & Alascio, P. C. (2018). Natural history and clinical characteristics of 50 patients with Wolfram syndrome. Endocrine, 61(3), 440–446. https://doi.org/10.1007/S12020-018-1608-2
Cardona, M., Ardila, A., Gómez, J. D., & Román-González, A. (2023). Wolfram syndrome 1 in two brothers treated with insulin pump. AACE Clinical Case Reports, 9(4), 125. https://doi.org/10.1016/J.AACE.2023.05.002
Catarinella, D., Festorazzi, C., Caldara, R., & Piemonti, L. (2025). Long-term follow-up of pancreatic islet transplantation in a patient with Wolfram syndrome: A case report. Acta Diabetologica, 62(11), 2031–2035. https://doi.org/10.1007/S00592-025-02558-4
Cockcroft, E. J., Narendran, P., & Andrews, R. C. (2020). Exercise-induced hypoglycaemia in type 1 diabetes. Experimental Physiology, 105(4), 590–599. https://doi.org/10.1113/EP088219
Collier, J. J., Wasserfall, C. H., Brehm, M. A., & Karlstad, M. D. (2025). Partial remission of type 1 diabetes: Do immunometabolic events define the honeymoon period? Diabetes, Obesity & Metabolism, 27(8), 4092–4101. https://doi.org/10.1111/DOM.16480
de Muijnck, C., ten Brink, J. B., Bergen, A. A., Boon, C. J. F., & van Genderen, M. M. (2023). Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum. Survey of Ophthalmology, 68(4), 641–654. https://doi.org/10.1016/j.survophthal.2023.01.012
Delprat, B., Maurice, T., & Delettre, C. (2018). Wolfram syndrome: MAMs’ connection? Cell Death & Disease, 9(3). https://doi.org/10.1038/S41419-018-0406-3
Du, D., Tuhuti, A., Ma, Y., Abuduniyimu, M., Li, S., Ma, G., Zynat, J., & Guo, Y. (2023). Wolfram syndrome type 1: A case series. Orphanet Journal of Rare Diseases, 18(1), 359. https://doi.org/10.1186/S13023-023-02938-5
Duan, L., Li, Q., Tong, A. L., Mao, J. F., Yu, M., Yuan, T., Chai, X. F., & Gu, F. (2018). Clinical characteristics of Wolfram syndrome in Chinese population and a novel frameshift mutation in WFS1. Frontiers in Endocrinology, 9, Article 18. https://doi.org/10.3389/FENDO.2018.00018
Evans, K. (2019). Diabetic ketoacidosis: Update on management. Clinical Medicine, 19(5), 396–398. https://doi.org/10.7861/CLINMED.2019-0284
Feingold, K. R. (2025). Atypical forms of diabetes. In Endotext. https://www.ncbi.nlm.nih.gov/books/NBK279128/
Fishman, L., & Ehrlich, R. M. (1986). Wolfram syndrome: Report of four new cases and a review of literature. Diabetes Care, 9(4), 405–408. https://doi.org/10.2337/DIACARE.9.4.405
Flatt, A. J. S., Bennett, D., Counter, C., Brown, A. L., White, S. A., & Shaw, J. A. M. (2020). β-cell and renal transplantation options for diabetes. Diabetic Medicine, 37(4), 580–592. https://doi.org/10.1111/DME.14177
Gomez-Muñoz, L., Dominguez-Bendala, J., Pastori, R. L., & Vives-Pi, M. (2024). Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus. Trends in Endocrinology and Metabolism, 35(2), 151–163. https://doi.org/10.1016/J.TEM.2023.10.005
Guan, Z., Li, H., Liu, R., Cai, C., Liu, Y., Li, J., Wang, X., Huang, S., Wu, L., Liu, D., Yu, S., Wang, Z., Shu, J., Hou, X., Yang, X., Jia, W., & Sheng, B. (2023). Artificial intelligence in diabetes management: Advancements, opportunities, and challenges. Cell Reports Medicine, 4(10), Article 101213. https://doi.org/10.1016/J.XCRM.2023.101213
Iafusco, D., Zanfardino, A., Piscopo, A., Curto, S., Troncone, A., Chianese, A., Rollato, A. S., Testa, V., Iafusco, F., Maione, G., Pennarella, A., Boccabella, L., Ozen, G., Palma, P. L., Mazzaccara, C., Tinto, N., & Del Giudice, E. M. (2022). Metabolic treatment of Wolfram syndrome. International Journal of Environmental Research and Public Health, 19(5), Article 2755. https://doi.org/10.3390/IJERPH19052755
Jurca, A. D., Galea-Holhos, L. B., Jurca, A. A., Atasie, D., Petchesi, C. D., Severin, E., & Jurca, C. M. (2024). Wolfram syndrome type I case report and review: Focus on early diagnosis and genetic variants. Medicina, 60(7), Article 1064. https://doi.org/10.3390/MEDICINA60071064
Kondo, M., Tanabe, K., Amo-Shiinoki, K., Hatanaka, M., Morii, T., Takahashi, H., Seino, S., Yamada, Y., & Tanizawa, Y. (2018). Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia, 61(10), 2189–2201. https://doi.org/10.1007/S00125-018-4679-Y
Li, Y., Gong, S., Li, M., Cai, X., Liu, W., Zhang, S., Ma, Y., Luo, Y., Zhou, L., Zhang, X., Huang, X., Gao, X., Hu, M., Li, Y., Ren, Q., Wang, Y., Zhou, X., Han, X., & Ji, L. (2023). The genetic and clinical characteristics of WFS1 related diabetes in Chinese early onset type 2 diabetes. Scientific Reports, 13(1), Article 9127. https://doi.org/10.1038/S41598-023-36334-7
Liiv, M., Vaarmann, A., Safiulina, D., Choubey, V., Gupta, R., Kuum, M., Janickova, L., Hodurova, Z., Cagalinec, M., Zeb, A., Hickey, M. A., Huang, Y. L., Gogichaishvili, N., Mandel, M., Plaas, M., Vasar, E., Loncke, J., Vervliet, T., Tsai, T. F., ... Kaasik, A. (2024). ER calcium depletion as a key driver for impaired ER-to-mitochondria calcium transfer and mitochondrial dysfunction in Wolfram syndrome. Nature Communications, 15(1), Article 6143. https://doi.org/10.1038/S41467-024-50502-X
Mohamed, F., Adams, C., & Mansfield, B. (2024). An unmet need: Pancreatic beta cell replacement. South African Medical Journal, 114(3), Article e1249. https://doi.org/10.7196/SAMJ.2024.V114I3B.1249
Okita, K. (2011). iPS cells for transplantation. Current Opinion in Organ Transplantation, 16(1), 96–100. https://doi.org/10.1097/MOT.0B013E32834252A2
Pallotta, M. T., Tascini, G., Crispoldi, R., Orabona, C., Mondanelli, G., Grohmann, U., & Esposito, S. (2019). Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives. Journal of Translational Medicine, 17(1). https://doi.org/10.1186/S12967-019-1993-1
Png, D., Yeoh, E., Tan, C., & Lim, S. C. (2023). A pair of siblings with Wolfram syndrome: A review of the literature and treatment options. Journal of Investigative Medicine High Impact Case Reports, 11, Article 23247096221150630. https://doi.org/10.1177/23247096221150631
Powers, A. C. (2021). Type 1 diabetes mellitus: Much progress, many opportunities. Journal of Clinical Investigation, 131(8), Article e142242. https://doi.org/10.1172/JCI142242
Ray, M. K., Chen, L., White, N. H., Ni, R., Hershey, T., & Marshall, B. A. (2022). Longitudinal progression of diabetes mellitus in Wolfram syndrome: The Washington University Wolfram Research Clinic experience. Pediatric Diabetes, 23(2), 212–218. https://doi.org/10.1111/PEDI.13291
Di Resta, C., Bellin, M., & Kõks, S. (2023). Genomics of Wolfram syndrome 1 (WFS1). Biomolecules, 13(9), Article 1346. https://doi.org/10.3390/BIOM13091346
Rigoli, L., Bramanti, P., Di Bella, C., & De Luca, F. (2018). Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. Pediatric Research, 83(5), 921–929. https://doi.org/10.1038/PR.2018.17
Rigoli, L., Caruso, V., Salzano, G., & Lombardo, F. (2022). Wolfram syndrome 1: From genetics to therapy. International Journal of Environmental Research and Public Health, 19(6), Article 3225. https://doi.org/10.3390/ijerph19063225
Rigoli, L., & Di Bella, C. (2012). Wolfram syndrome 1 and Wolfram syndrome 2. Current Opinion in Pediatrics, 24(4), 512–517. https://doi.org/10.1097/MOP.0B013E328354CCDF
Rohayem, J., Ehlers, C., Wiedemann, B., Holl, R., Oexle, K., Kordonouri, O., Salzano, G., Meissner, T., Burger, W., Schober, E., Huebner, A., Lee-Kirsch, M. A., Herr, M., Menzel, U., Knerr, I., Strier, U., Reiners-Franz, U., Otten, A., Bennink, H., ... Kuhlmann, B. (2011). Diabetes and neurodegeneration in Wolfram syndrome: A multicenter study of phenotype and genotype. Diabetes Care, 34(7), 1503–1510. https://doi.org/10.2337/DC10-1937
Scully, K. J., & Wolfsdorf, J. I. (2020). Efficacy of GLP-1 agonist therapy in autosomal dominant WFS1-related disorder: A case report. Hormone Research in Paediatrics, 93(6), 409–414. https://doi.org/10.1159/000510852
Seppa, K., Toots, M., Reimets, R., Jagomäe, T., Koppel, T., Pallase, M., Hasselholt, S., Krogsbæk Mikkelsen, M., Randel Nyengaard, J., Vasar, E., Terasmaa, A., & Plaas, M. (2019). GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome. Scientific Reports, 9(1), Article 15742. https://doi.org/10.1038/S41598-019-52295-2
Serbis, A., Rallis, D., Giapros, V., Galli-Tsinopoulou, A., & Siomou, E. (2023). Wolfram syndrome 1: A pediatrician’s and pediatric endocrinologist’s perspective. International Journal of Molecular Sciences, 24(4), Article 3690. https://doi.org/10.3390/IJMS24043690
Toppings, N. B., McMillan, J. M., Au, P. Y. B., Suchowersky, O., & Donovan, L. E. (2018). Wolfram syndrome: A case report and review of clinical manifestations, genetics pathophysiology, and potential therapies. Case Reports in Endocrinology, 2018, Article 9412676. https://doi.org/10.1155/2018/9412676
Urano, F. (2016). Wolfram syndrome: Diagnosis, management, and treatment. Current Diabetes Reports, 16(1), Article 6. https://doi.org/10.1007/S11892-015-0702-6
Wang, M., & Hng, T. M. (2021). HbA1c: More than just a number. Australian Journal of General Practice, 50(9), 628–632. https://doi.org/10.31128/AJGP-03-21-5866
Wang, W., Liu, H., Xiao, S., Liu, S., Li, X., & Yu, P. (2017). Effects of insulin plus glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating type 1 diabetes mellitus: A systematic review and meta-analysis. Diabetes Therapy, 8(4), 727. https://doi.org/10.1007/S13300-017-0282-3
Zhong, T., Tang, R., Gong, S., Li, J., Li, X., & Zhou, Z. (2020). The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms. Diabetes/Metabolism Research and Reviews, 36(2). https://doi.org/10.1002/DMRR.3207
Zmyslowska, A., Stanczak, M., Nowicka, Z., Waszczykowska, A., Baranska, D., Fendler, W., Borowiec, M., & Młynarski, W. (2020). Serum microRNA as indicators of Wolfram syndrome’s progression in neuroimaging studies. BMJ Open Diabetes Research & Care, 8(2), Article e001379. https://doi.org/10.1136/BMJDRC-2020-001379
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dominika Darasz, Dominik Zając, Marek Łobaziewicz, Patrycja Powaga, Michał Sęk, Aleksandra Wajs, Aleksandra Gródek, Julia Kierner, Daria Valipur Kolti, Amelia Żurek
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
